Frank Douglas Elected To The ALTANA Pharma AG (AAA) Supervisory Board
10/19/2005 5:12:59 PM
BAD HOMBURG, Germany--(BUSINESS WIRE)--March 10, 2005--ALTANA AG (NYSE:AAA)(FSE:ALT) announced today that Dr. Frank Douglas, former Head of Research and Development at Aventis, has been newly elected to the Supervisory Board of ALTANA Pharma AG.
"Dr. Frank Douglas has a lot to contribute to the ALTANA Pharma Supervisory Board: his wide-ranging medical and pharmaceutical expertise, his excellent knowledge of the industry and his international experience", commented Dr. Nikolaus Schweickart, CEO ALTANA AG and Chairman of the Supervisory Board of ALTANA Pharma AG.
comments powered by